Biodesix
BDSX
59 hedge funds and large institutions have $33.4M invested in Biodesix in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 10 closing their positions.
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
2% more funds holding
Funds holding: 58 → 59 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.19% less ownership
Funds ownership: 2.02% → 1.83% (-0.19%)
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
63% less capital invested
Capital invested by funds: $89.9M → $33.4M (-$56.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$527K |
| 2 |
Millennium Management
New York
|
+$130K |
| 3 |
Squarepoint
New York
|
+$123K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$99K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$70.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.87M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.83M |
| 3 |
AE
AMH Equity
Great Neck,
New York
|
-$580K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$495K |
| 5 |
6CM
683 Capital Management
New York
|
-$394K |
BDSX Hedge Fund Activity: Q1 2025 in Review
59 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2025, worth a combined $33.4M — down 63% from $89.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BDSX positions and 10 closed out — a net gain of 1 holder — while 13 added to existing stakes and 19 trimmed.
The largest buyer was Monashee Investment Management, adding an estimated $527K. The largest seller was Farallon Capital Management, cutting an estimated $1.87M.
- 59 institutional investors held Biodesix (BDSX) as of Q1 2025, up from 58 in Q4 2024.
- Funds reported $33.4M of Biodesix stock for Q1 2025, down 63% quarter-over-quarter.
- 11 funds opened new Biodesix positions in Q1 2025 and 10 closed out, a net change of +1 holder.
- The largest Biodesix buyer in Q1 2025 was Monashee Investment Management, an estimated $527K added.
- The largest Biodesix seller in Q1 2025 was Farallon Capital Management, an estimated $1.87M sold.
Based on aggregated 13F filings for Q1 2025.